title: Rituximab-hyperfractionated cyclophosphamide, vincristine, adriamycin and dexamethasone alternating with high-dose cytarabine and methotrexate for aggressive non-Hodgkin lymphoma.
authors: Disni
authors: D
authors: Muringampurath-John
authors: Christopher R
authors: CR
authors: Flowers
authors: Michael
authors: M
authors: Toscano
authors: Chen
authors: C
authors: Zhengjia
authors: Jonathan L
authors: JL
authors: Kaufman
authors: Martha
authors: M
authors: Arellano
authors: Leon
authors: L
authors: Bernal-Mizrachi
authors: Leonard T
authors: LT
authors: Heffner
authors: Mary-Jo
authors: MJ
authors: Lechowicz
authors: Morgan
authors: M
authors: McLemore
authors: Elliott
authors: E
authors: Winton
authors: David L
authors: DL
authors: Jaye
authors: Sagar
authors: S
authors: Lonial
authors: Hanna Jean
authors: HJ
authors: Khoury
mesh_terms: D000328:Adult; D058846:Antibodies, Monoclonal, Murine-Derived / Q000008:administration & dosage; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D005591:Chemical Fractionation; D003520:Cyclophosphamide / Q000008:administration & dosage; D003561:Cytarabine / Q000008:administration & dosage; D003907:Dexamethasone / Q000008:administration & dosage; D004305:Dose-Response Relationship, Drug; D004317:Doxorubicin / Q000008:administration & dosage; D006801:Humans; D053208:Kaplan-Meier Estimate; D008228:Lymphoma, Non-Hodgkin / Q000188:drug therapy* / Q000473:pathology; D008875:Middle Aged; D000069283:Rituximab; D016896:Treatment Outcome; D014750:Vincristine / Q000008:administration & dosage; D055815:Young Adult
chemical_list: D058846:Antibodies, Monoclonal, Murine-Derived; D003561:Cytarabine; D000069283:Rituximab; D014750:Vincristine; D003907:Dexamethasone; D004317:Doxorubicin; D003520:Cyclophosphamide